Everything Moving Ahead Of The Fed… And The Face Of Fear Trade 9/17/24
CNBC's "Fast Money"
00:00
Examining Future Price Cuts and Market Dynamics for Weight Loss Drugs
This chapter explores the potential 30 to 40% price cuts for Ozempic as it faces future negotiations, discussing the implications for similar drugs like Monjaro and Zepbound. It delves into the uncertainty around pricing timelines and the market impact as these weight loss treatments approach patent expiration and new alternatives emerge.
Play episode from 29:15
Transcript
